rewirebio.iobenchmarks
Result

Likelihood ratio (interval: low) of BayesDel with ENIGMA BRCA gene-specific score categories on BRCA2 functional reference calibration set

0.21 Likelihood ratio (interval: low)

Methods

Tested configuration
BayesDel with ENIGMA BRCA gene-specific score categories
Protocol
BRCA2 BayesDel evidence calibration
Dataset
BRCA2 functional reference calibration set
Related family profiles
BayesDel
Evaluation
BRCA2 BayesDel gene-specific calibration
Coverage
Not reported scored / Not reported eligible
Uncertainty
95% CI 0.14 to 0.33
Evidence
Author-reported evaluation · source checkedEvidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, likelihood_ratio

A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.

Reproduction

Split
Not reported
Adaptation
Not reported
Scoring implementation
Source-defined endpoint; see result source_locator

No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.

Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Reported result
0.21
Individual claims
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Table 2, BRCA2, BayesDel ≤0.18, likelihood_ratio

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

source checked

["automated-source-review"] · 2026-09-30

author reported

Audit details

Transcription from inspected primary source. No execution, independent replication or human scientific review.

Field: attributes.printed_value

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: uc-clinical-20260930-enigma-brca2-low-likelihood-ratio

areas
dna-genomes
contexts
clinical_research
metric
likelihood-ratio
unit
unitless
printed value
0.21
numeric value
0.21
metric direction
unknown
uncertainty
type: confidence_interval; level: 0.95; lower: 0.14; upper: 0.33; printed: 0.14–0.33
source locator
Table 2, BRCA2, BayesDel ≤0.18, likelihood_ratio
review
method: automated-source-review; reviewer: codex; date: 2026-09-30; note: Transcription from inspected primary source. No execution, independent replication or human scientific review.; source id: uc-clinical-20260930-source-enigma; reviewer note: role: clinical coverage worker
score category
≤0.18
metric qualifier
interval: low
Related records

Suggest a correction